Pulse Biosciences (PLSE) Return on Invested Capital (2022)
Pulse Biosciences' quarterly Return on Invested Capital came in at 0.04% in Q3 2022, down 59.89% quarter-over-quarter from 0.03% in Q2 2022.
Pulse Biosciences has reported Return on Invested Capital for 1 years, with the latest figure at 0.04% in Q3 2022.
- For the quarter ending Q3 2022, Return on Invested Capital changed N/A year-over-year to 0.04%; the trailing twelve-month figure through Sep 2022 stood at 0.04% (changed N/A YoY), and the FY2015 full-year result was 0.0%, changed N/A from the prior year.
- Return on Invested Capital for Q3 2022 stood at 0.04%, down from 0.03% in the prior quarter.
- The five-year high for Return on Invested Capital was 0.02% in Q1 2022, with the low at 0.04% in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 0.00% |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | 0.00% |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 0.00% |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 0.00% |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 0.00% |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 0.00% |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 0.00% |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 0.00% |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 0.00% |
| 10 | Pulse Biosciences | 1.72 Bn | 1.72 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -0.04% |
| Jun 30, 2022 | -0.03% |
| Mar 31, 2022 | -0.02% |